Skip to main navigation Skip to search Skip to main content

Detailed analysis of treatment satisfaction with oral agents plus either basal insulin glargine or mealtime analogue insulin in patients with Type 2 diabetes – the APOLLO study

Research output: Contribution to journalArticlepeer-review

107 Downloads (Pure)
Original languageEnglish
Pages (from-to)P1009
JournalDiabetic Medicine
Volume23
Issue number360
Publication statusPublished - 2006

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this